Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application

Introduction: Graft infections are severe complications. Surgical resection of infected aortic stent grafts is associated with high mortality and morbidity. Therefore, alternatives or adjuncts to antibiotic treatment and extensive surgery are urgently needed. Report: A 67 year old woman was admitted...

Full description

Bibliographic Details
Main Authors: Eberhard Grambow, Simon Junghans, Jens Christian Kröger, Emil Christian Reisinger, Bernd Joachim Krause, Justus Groß
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:EJVES Vascular Forum
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666688X22000193
_version_ 1797990667742347264
author Eberhard Grambow
Simon Junghans
Jens Christian Kröger
Emil Christian Reisinger
Bernd Joachim Krause
Justus Groß
author_facet Eberhard Grambow
Simon Junghans
Jens Christian Kröger
Emil Christian Reisinger
Bernd Joachim Krause
Justus Groß
author_sort Eberhard Grambow
collection DOAJ
description Introduction: Graft infections are severe complications. Surgical resection of infected aortic stent grafts is associated with high mortality and morbidity. Therefore, alternatives or adjuncts to antibiotic treatment and extensive surgery are urgently needed. Report: A 67 year old woman was admitted with a methicillin sensitive Staphylococcus aureus infected stent graft in the thoracic aorta. Local infection was confirmed by PET-CT imaging. Surgical resection of the stent graft was not feasible because of comorbidities. Therefore, a three step approach for local bacteriophage treatment was performed as a last resort treatment. Firstly, the para-aortic tissue was debrided via left thoracotomy, a bacteriophage suspension was applied on the outer surface of the aorta, and a vacuum irrigation system was installed. After repeated alternating instillation of the bacteriophage suspension for three days, as a second step, the vacuum sponges were removed and a bacteriophage containing gel was applied locally on the outer surface of the aorta. In the third step, the bacteriophage containing gel was applied to a thoracic stent graft, which in turn was placed endovascularly into the infected stent. Discussion: After 28 days, the patient was discharged from hospital with normalised infection parameters. PET-CT imaging at three and 12 months post-intervention did not show signs of infection in or around the thoracic aorta. This Case demonstrates successful treatment of an infected endovascular stent graft by application of bacteriophages both to extravascular and, as a novel approach, endovascular sites using a bacteriophage coated stent graft.
first_indexed 2024-04-11T08:40:08Z
format Article
id doaj.art-adbf76ad28c3425e9fb8094e818826a5
institution Directory Open Access Journal
issn 2666-688X
language English
last_indexed 2024-04-11T08:40:08Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series EJVES Vascular Forum
spelling doaj.art-adbf76ad28c3425e9fb8094e818826a52022-12-22T04:34:14ZengElsevierEJVES Vascular Forum2666-688X2022-01-01562023Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage ApplicationEberhard Grambow0Simon Junghans1Jens Christian Kröger2Emil Christian Reisinger3Bernd Joachim Krause4Justus Groß5Department for General, Visceral-, Thoracic-, Vascular- and Transplantation Surgery, Rostock University Medical Centre, Rostock, Germany; Corresponding author. Department for General, Visceral-, Vascular- and Transplantation Surgery, University Medical Centre Rostock, Schillingallee 35, 18057 Rostock, Germany.G. Pohl-Boskamp GmbH & Co. KG, Hohenlockstedt, GermanyDepartment of Diagnostic, Interventional, Neuro- and Paediatric Radiology, Rostock University Medical Centre, Rostock, GermanyDivision of Tropical Medicine and Infectious Diseases, Centre of Internal Medicine II, University Medical Centre Rostock, Rostock, GermanyDepartment of Nuclear Medicine, Rostock University Medical Centre, Rostock, GermanyDepartment for General, Visceral-, Thoracic-, Vascular- and Transplantation Surgery, Rostock University Medical Centre, Rostock, GermanyIntroduction: Graft infections are severe complications. Surgical resection of infected aortic stent grafts is associated with high mortality and morbidity. Therefore, alternatives or adjuncts to antibiotic treatment and extensive surgery are urgently needed. Report: A 67 year old woman was admitted with a methicillin sensitive Staphylococcus aureus infected stent graft in the thoracic aorta. Local infection was confirmed by PET-CT imaging. Surgical resection of the stent graft was not feasible because of comorbidities. Therefore, a three step approach for local bacteriophage treatment was performed as a last resort treatment. Firstly, the para-aortic tissue was debrided via left thoracotomy, a bacteriophage suspension was applied on the outer surface of the aorta, and a vacuum irrigation system was installed. After repeated alternating instillation of the bacteriophage suspension for three days, as a second step, the vacuum sponges were removed and a bacteriophage containing gel was applied locally on the outer surface of the aorta. In the third step, the bacteriophage containing gel was applied to a thoracic stent graft, which in turn was placed endovascularly into the infected stent. Discussion: After 28 days, the patient was discharged from hospital with normalised infection parameters. PET-CT imaging at three and 12 months post-intervention did not show signs of infection in or around the thoracic aorta. This Case demonstrates successful treatment of an infected endovascular stent graft by application of bacteriophages both to extravascular and, as a novel approach, endovascular sites using a bacteriophage coated stent graft.http://www.sciencedirect.com/science/article/pii/S2666688X22000193Antibiotic resistanceGraft infectionPhage therapyStaphylococcus aureus sepsis
spellingShingle Eberhard Grambow
Simon Junghans
Jens Christian Kröger
Emil Christian Reisinger
Bernd Joachim Krause
Justus Groß
Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application
EJVES Vascular Forum
Antibiotic resistance
Graft infection
Phage therapy
Staphylococcus aureus sepsis
title Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application
title_full Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application
title_fullStr Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application
title_full_unstemmed Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application
title_short Treatment of an Infected TEVAR with Extra- and Endovascular Bacteriophage Application
title_sort treatment of an infected tevar with extra and endovascular bacteriophage application
topic Antibiotic resistance
Graft infection
Phage therapy
Staphylococcus aureus sepsis
url http://www.sciencedirect.com/science/article/pii/S2666688X22000193
work_keys_str_mv AT eberhardgrambow treatmentofaninfectedtevarwithextraandendovascularbacteriophageapplication
AT simonjunghans treatmentofaninfectedtevarwithextraandendovascularbacteriophageapplication
AT jenschristiankroger treatmentofaninfectedtevarwithextraandendovascularbacteriophageapplication
AT emilchristianreisinger treatmentofaninfectedtevarwithextraandendovascularbacteriophageapplication
AT berndjoachimkrause treatmentofaninfectedtevarwithextraandendovascularbacteriophageapplication
AT justusgroß treatmentofaninfectedtevarwithextraandendovascularbacteriophageapplication